131 related articles for article (PubMed ID: 28662285)
1. Genetic predisposition for chronic venous insufficiency in several genes for matrix metalloproteinases (MMP-2, MMP-9, MMP-12) and their inhibitor TIMP-2.
Slonková V; Slonková V; Vašků A; Vašků V
J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1746-1752. PubMed ID: 28662285
[TBL] [Abstract][Full Text] [Related]
2. [Study on the association of SNPs of MMP-2 and TIMP-2 genes with the risk of endometriosis and adenomyosis].
Zhao XW; Li Y; Wang N; Zhao J; Li XL; Liu Q; Jia JH; Yang ZF; Kang S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):280-3. PubMed ID: 18543216
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study.
Ben Néjima D; Ben Zarkouna Y; Gammoudi A; Manai M; Boussen H
Tumour Biol; 2015 May; 36(5):3815-22. PubMed ID: 25656607
[TBL] [Abstract][Full Text] [Related]
4. Role of MMP-2, MMP-7, MMP-9 and TIMP-2 in the development of recurrent depressive disorder.
Bobińska K; Szemraj J; Czarny P; Gałecki P
J Affect Disord; 2016 Nov; 205():119-129. PubMed ID: 27434116
[TBL] [Abstract][Full Text] [Related]
5. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
Srivastava P; Kapoor R; Mittal RD
Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201
[TBL] [Abstract][Full Text] [Related]
6. [Association of SNPs in the promoter of MMP-2 and TIMP-2 genes with epithelial ovarian cancer].
Li XL; Kang S; Zhao XW; Zhang XJ; Zhou RM; Wang N; Jia JH; Zhao J; Li Y
Yi Chuan; 2008 Apr; 30(4):455-62. PubMed ID: 18424416
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non-Hodgkin's lymphoma.
Diao LP; Ma H; Wei GC; Li T; Liu HS; Liu LH; Wu LL; Zhao GM; Gao YH
Int J Cancer; 2012 Sep; 131(5):1095-103. PubMed ID: 22020421
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase (MMP)-8 and tissue inhibitor of MMP-1 (TIMP-1) gene polymorphisms in generalized aggressive periodontitis: gingival crevicular fluid MMP-8 and TIMP-1 levels and outcome of periodontal therapy.
Emingil G; Han B; Gürkan A; Berdeli A; Tervahartiala T; Salo T; Pussinen PJ; Köse T; Atilla G; Sorsa T
J Periodontol; 2014 Aug; 85(8):1070-80. PubMed ID: 24283658
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in MMP-2 and TIMP-2 in Turkish patients with prostate cancer.
Yaykaşli KO; Kayikçi MA; Yamak N; Soğuktaş H; Düzenli S; Arslan AO; Metın A; Kaya E; Hatıpoğlu ÖF
Turk J Med Sci; 2014; 44(5):839-43. PubMed ID: 25539555
[TBL] [Abstract][Full Text] [Related]
10. The GC + CC genotype at position -418 in TIMP-2 promoter and the -1575GA/-1306CC genotype in MMP-2 is genetic predisposing factors for prevalence of moyamoya disease.
Park YS; Jeon YJ; Kim HS; Han IB; Oh SH; Kim DS; Kim NK
BMC Neurol; 2014 Oct; 14():180. PubMed ID: 25280484
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the MMP-9 (C-1562 T) and TIMP-2 (G-418C) gene promoter polymorphisms in patients with chronic periodontitis.
de Souza AP; Trevilatto PC; Scarel-Caminaga RM; de Brito RB; Barros SP; Line SR
J Clin Periodontol; 2005 Feb; 32(2):207-11. PubMed ID: 15691353
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease.
Marson BP; Lacchini R; Belo V; Dickel S; da Costa BP; Poli de Figueiredo CE; Tanus-Santos JE
Am J Nephrol; 2012; 35(3):209-15. PubMed ID: 22302011
[TBL] [Abstract][Full Text] [Related]
13. Presence of matrix metalloproteinase-2 and tissue inhibitor matrix metalloproteinase-2 gene polymorphisms and immunohistochemical expressions in intracranial meningiomas.
Coven İ; Ozer O; Ozen O; Şahin Fİ; Altinors N
J Neurosurg; 2014 Dec; 121(6):1478-82. PubMed ID: 25259564
[TBL] [Abstract][Full Text] [Related]
14. Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease.
Meijer MJ; Mieremet-Ooms MA; van Hogezand RA; Lamers CB; Hommes DW; Verspaget HW
World J Gastroenterol; 2007 Jun; 13(21):2960-6. PubMed ID: 17589947
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-2, -9, -12, and tissue inhibitor of metalloproteinase 2 gene polymorphisms and cutaneous expressions in patients with Behçet's disease.
Park KS; Min Y; Park SR; Kim EH; Lee DJ; Bang D; Lee ES
Tissue Antigens; 2012 May; 79(5):333-9. PubMed ID: 22428754
[TBL] [Abstract][Full Text] [Related]
16. Association of Polymorphisms of the Tissue Inhibitors of Metalloproteinases- 1 and -2 with Alzheimer's Disease in Taiwan.
Ho WM; Lee YS; Chen CM; Wu YY; Hsu WC; Huang YH; Chen YC
Curr Alzheimer Res; 2021; 18(6):505-512. PubMed ID: 34561981
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the Promoters of the MMP-2 and TIMP-2 Genes Are Associated with Spontaneous Deep Intracerebral Hemorrhage in the Taiwan Population.
Chen YC; Ho WM; Lee YS; Chen HW; Chen CM
PLoS One; 2015; 10(11):e0142482. PubMed ID: 26551785
[TBL] [Abstract][Full Text] [Related]
18. Analysis of MMP-7 and TIMP-2 gene polymorphisms in coronary artery disease and myocardial infarction: A Turkish case-control study.
Alp E; Yilmaz A; Tulmac M; Ugras Dikmen A; Cengel A; Yalcin R; Menevse ES
Kaohsiung J Med Sci; 2017 Feb; 33(2):78-85. PubMed ID: 28137415
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of the matrix metalloproteinase-3 (MMP-3) and tissue inhibitors of matrix metalloproteinases-1 (TIMP-1) modulate the development of ankylosing spondylitis.
Wei JC; Lee HS; Chen WC; Shiu LJ; Yang SF; Wong RH
Ann Rheum Dis; 2009 Nov; 68(11):1781-6. PubMed ID: 19019896
[TBL] [Abstract][Full Text] [Related]
20. TIMP-2 gene polymorphism is associated with intracerebral hemorrhage.
Reuter B; Bugert P; Stroick M; Bukow S; Griebe M; Hennerici MG; Fatar M
Cerebrovasc Dis; 2009; 28(6):558-63. PubMed ID: 19844095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
